The Affinity Health System Institutional Review Board ensures the ethical treatment of people who participate in health care studies.
Under FDA regulations, an Institutional Review Board (IRB) is an appropriately constituted group that has been formally designated to review and monitor biomedical research involving human subjects. In accordance with FDA regulations, an IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. This group review serves an important role in the protection of the rights and welfare of human research subjects.
The purpose of IRB review is to assure, both in advance and by periodic review, that appropriate steps are taken to protect the rights and welfare of humans participating as subjects in the research. To accomplish this purpose, IRBs use a group process to review research protocols and related materials (e.g., informed consent documents and investigator brochures) to ensure protection of the rights and welfare of human subjects of research.
Contact the Affinity Health System IRB:
IRB Chairperson: Daniel Neunaber, PhD
Affinity Medical Group
1501 S. Madison St.
Appleton, WI 54915
Phone (920) 730-4411
Secretary: Carlene Enama
Affinity Health System
1570 Midway Place
Menasha, WI 54952
Phone: (920) 720-1467